Successful sodium thiosulphate treatment for recurrent calcium urolithiasis

Clin Nephrol. 1985 Feb;23(2):63-7.

Abstract

Thirty-four idiopathic rapid calcium stone formers (24 male/10 female) were studied. Their ages ranged from 20 to 60 years (40 +/- 11) and all had good renal function. The trial comprised two consecutive periods of 3 years and 4 years duration respectively. In the first (control period), the patients were maintained on a customary diet with an adequate fluid intake sufficient to produce about 2 liters of urine daily. In the second (treatment period), they received a similar diet plus 20 mmol of sodium thiosulphate daily. New stone development fell from 100 in the control period to 15 in the treatment period, corresponding to a rate of 0.98 and 0.11 per year (p less than 0.001). It is suggested that the benefit from sodium thiosulphate results from calcium thiosulphate formation in urine, a salt with a molar solubility of 250 to 100.000-fold greater than that of other urinary calcium salts.

Publication types

  • Clinical Trial

MeSH terms

  • Adult
  • Calcium / metabolism*
  • Calcium / urine
  • Calcium Compounds*
  • Calcium Oxalate / urine
  • Calcium Phosphates / urine
  • Calcium Sulfate / urine
  • Citrates / urine
  • Citric Acid
  • Clinical Trials as Topic
  • Diet
  • Female
  • Follow-Up Studies
  • Humans
  • Magnesium / metabolism
  • Male
  • Middle Aged
  • Phosphorus / metabolism
  • Recurrence
  • Solubility
  • Thiosulfates / therapeutic use*
  • Thiosulfates / urine
  • Time Factors
  • Urinary Calculi / drug therapy*
  • Urinary Calculi / prevention & control

Substances

  • Calcium Compounds
  • Calcium Phosphates
  • Citrates
  • Thiosulfates
  • Calcium Oxalate
  • Phosphorus
  • Citric Acid
  • calcium thiosulfate
  • sodium thiosulfate
  • Magnesium
  • Calcium
  • Calcium Sulfate